Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

  • Filters activated: Field: Title+Word. Clear all
1.

Finding common ground: Academics at the intersection of addiction and criminal justice.

Kinnard EN, Netherland J, Marshall T, Arnold A.

Addict Behav. 2019 Mar;90:452-453. doi: 10.1016/j.addbeh.2018.12.019. Epub 2018 Dec 19. No abstract available.

PMID:
30611575
2.

White opioids: Pharmaceutical race and the war on drugs that wasn't.

Netherland J, Hansen H.

Biosocieties. 2017 Jun;12(2):217-238. doi: 10.1057/biosoc.2015.46. Epub 2017 Jun 28.

3.

Is the Prescription Opioid Epidemic a White Problem?

Hansen H, Netherland J.

Am J Public Health. 2016 Dec;106(12):2127-2129. No abstract available.

4.
5.

Roundtable on Urban Living Environment Research (RULER).

Vlahov D, Agarwal SR, Buckley RM, Caiaffa WT, Corvalan CF, Ezeh AC, Finkelstein R, Friel S, Harpham T, Hossain M, de Faria Leao B, Mboup G, Montgomery MR, Netherland JC, Ompad DC, Prasad A, Quinn AT, Rothman A, Satterthwaite DE, Stansfield S, Watson VJ.

J Urban Health. 2011 Oct;88(5):793-857. doi: 10.1007/s11524-011-9613-2.

6.

Policy implications of integrating buprenorphine/naloxone treatment and HIV care.

Finkelstein R, Netherland J, Sylla L, Gourevitch MN, Cajina A, Cheever L; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S98-S104. doi: 10.1097/QAI.0b013e31820a9a97.

PMID:
21317602
7.

The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.

Schackman BR, Leff JA, Botsko M, Fiellin DA, Altice FL, Korthuis PT, Sohler N, Weiss L, Egan JE, Netherland J, Gass J, Finkelstein R; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S76-82. doi: 10.1097/QAI.0b013e31820a9a66.

8.

Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.

Weiss L, Netherland J, Egan JE, Flanigan TP, Fiellin DA, Finkelstein R, Altice FL; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S68-75. doi: 10.1097/QAI.0b013e31820a8226.

PMID:
21317597
9.

Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care.

Egan JE, Netherland J, Gass J, Finkelstein R, Weiss L; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S46-53. doi: 10.1097/QAI.0b013e3182097561.

PMID:
21317594
10.

The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment.

Weiss L, Egan JE, Botsko M, Netherland J, Fiellin DA, Finkelstein R.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S7-13. doi: 10.1097/QAI.0b013e3182097426.

PMID:
21317598
11.

The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment.

Egan JE, Casadonte P, Gartenmann T, Martin J, McCance-Katz EF, Netherland J, Renner JA, Weiss L, Saxon AJ, Fiellin DA.

J Gen Intern Med. 2010 Sep;25(9):936-41. doi: 10.1007/s11606-010-1377-y. Epub 2010 May 11.

12.

Feasibility of using audio computer-assisted self-interview (ACASI) screening in routine HIV care.

Schackman BR, Dastur Z, Rubin DS, Berger J, Camhi E, Netherland J, Ni Q, Finkelstein R.

AIDS Care. 2009 Aug;21(8):992-9. doi: 10.1080/09540120802657506.

PMID:
20024755
13.

Factors affecting willingness to provide buprenorphine treatment.

Netherland J, Botsko M, Egan JE, Saxon AJ, Cunningham CO, Finkelstein R, Gourevitch MN, Renner JA, Sohler N, Sullivan LE, Weiss L, Fiellin DA; BHIVES Collaborative.

J Subst Abuse Treat. 2009 Apr;36(3):244-51. doi: 10.1016/j.jsat.2008.06.006. Epub 2008 Aug 20.

14.

Adherence to HAART: perspectives from clients in treatment support programs.

Weiss L, French T, Waters M, Netherland J, Agins B, Finkelstein R.

Psychol Health Med. 2006 May;11(2):155-70.

PMID:
17129905
15.

A vulnerable population in a time of crisis: drug users and the attacks on the World Trade Center.

Weiss L, Fabri A, McCoy K, Coffin P, Netherland J, Finkelstein R.

J Urban Health. 2002 Sep;79(3):392-403.

16.

Supplemental Content

Loading ...
Support Center